Published in Oncology Business Week, May 30th, 2004
The early stage life sciences venture has created an innovative approach in which the starting point for drug discovery is the antibody itself, as opposed to more common drug discovery initiatives that begin with a "drug target."
The PBDC investment will be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.